Mechanical thrombectomy outcomes in large vessel stroke with high international normalized ratio

J Neurol Sci. 2019 Jan 15:396:193-198. doi: 10.1016/j.jns.2018.11.019. Epub 2018 Nov 19.

Abstract

Objective: Evaluating the safety and efficacy of mechanical thrombectomy (MT) in acute stroke patients due to emergent large vessel occlusion (ELVO) with high international-normalized-ratio (INR).

Methods: Consecutive ELVO patients treated with MT were evaluated from two centers. Outcome measures included symptomatic-intracranial-hemorrhage(sICH), three-month mortality, successful reperfusion(SR), and 3-month functional-independence(FI; mRS-scores of 0-2). Additionally, a meta-analysis of available cohort studies was performed to evaluate safety and efficacy of MT in ELVO patients with high INR.

Results: A total of 315 ELVO patients were evaluated. Of those 10 patients had INR >1.7 [mean age 63.5 ± 15, median NIHSS-score: 17 points (IQR 14-22)],and remaining 305 ELVO patients had INR ≤ 1.7 ([mean age 62 ± 14.4, median NIHSS-score: 17 points (IQR 12-21)]. Patients with high INR did not differ in terms of sICH (10.0% vs. 6.9%; p = .706), 3-month mortality (20.0% vs. 24.2%; p = .762), SR (88.9% vs. 69.4%; p = .209) and 3-month FI (50% vs. 49.3%; p = .762) compared to the rest. Meta-analysis of available studies (n = 5) showed that high INR was not related to sICH (OR: 0.94, 95%CI: 0.42-2.07; p = .88), 3-month mortality (OR: 1.07, 95%CI: CI 0.72-1.60; p = .73) and 3-month FI (OR: 0.69, 95%CI: 0.34-1.40; p = .30).

Conclusions: MT can be performed safely and effectively in ELVO patients with high INR.

Keywords: Efficacy; International normalized ratio; Large vessel occlusion; Safety; Thrombectomy.

Publication types

  • Meta-Analysis
  • Multicenter Study

MeSH terms

  • Aged
  • Female
  • Humans
  • International Normalized Ratio*
  • Male
  • Mechanical Thrombolysis / methods*
  • Middle Aged
  • Retrospective Studies
  • Severity of Illness Index
  • Stroke / mortality
  • Stroke / therapy*
  • Thrombectomy / methods*
  • Treatment Outcome*